1Duhaylongsod FG,Lowe VJ,Patz EF Jr,et al.Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography[].The Annals of Thoracic Surgery.1995
2Lowe VJ,Fletcher JW,Gobar L,et al.Prospective investigation of positron emission tomography in lung nodules[].Journal of Clinical Oncology.1998
3Laubenbacher C,Saumweber D,Wagner-Manslau C,et al.Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas[].The Journal of Nuclear Medicine.1995
4Smith TA.FDG uptake, tumour characteristics and response to therapy:a review[].Nuclear Medicine Communications.1998
5Vansteenkiste J,Stoobants S,Delyn P,et al.Prognostic significance of FDG-PET after induction chemotherapy in stage ⅢA-N2 non-small cell lung cancer (N2-NSCLC) : analysis of 13 cases[].Proceedings of the American Society of Clinical Oncology.1998
6Al-Sugair A,Coleman RE.Applications of PET in lung cancer[].Seminars in Nuclear Medicine.1998
7Bury T,Dowlati A,Paulus P,et al.Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer[].European Respiratory Journal.1997
8Lowe VJ,Naunheim KS.Current role of positron emission tomography in thoracic oncology[].Thorax.1998
9Patz EF Jr,Lowe VJ,Goodman PC,et al.Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma[].Chest.1995
